Genital psoriasis (which can either be plaque psoriasis or inverse psoriasis ... Psoriasis can also affect the skin around the ear (including the ear canal). In rare cases, psoriasis can also ...

Get Instant Summarized Text (Gist) The FDA has approved Zoryve (roflumilast) 0.3% topical foam for once-daily treatment of plaque psoriasis on the scalp and body in patients aged 12 and older ...

FDA Approves Topical Foam for Plaque Psoriasis of the Scalp and Body Approval is for once-daily 0.3 percent roflumilast topical foam for patients 12 years and older Photo: Arcutis Biotherapeutics By: ...

Stress reduction may help relieve the pain and itch of psoriasis plaques. Yoga also may improve your range of motion if you have psoriatic arthritis. The National Psoriasis Foundation recommends ...

FDA Approves Topical Foam for Plaque Psoriasis of the Scalp and Body By Lori Solomon HealthDay ReporterTUESDAY, May 27, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved ...

For patients with plaque psoriasis, there is no difference in the effectiveness of adalimumab monotherapy versus adalimumab with concomitant methotrexate. WEDNESDAY, June 4, 2025 (HealthDay News) ...

Omega-3s have been proven to help reduce psoriasis symptoms. Read on for more about omega-3s and which foods include them. Share on Pinterest Pixel Stories/Stocksy United Psoriasis is an ...

TUESDAY, May 27, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Zoryve (roflumilast) topical foam 0.3 percent for the treatment of plaque psoriasis of the scalp and ...

J&J is hoping to show that the peptide drug can be a more patient-friendly alternative to injectable biologics for plaque psoriasis, including drugs working on IL-23, such as J&J's own Tremfya ...

has announced the successful completion of patient enrollment in its pivotal Phase 3 ONWARD clinical program for ESK-001, a treatment for moderate-to-severe plaque psoriasis, involving over 1,700 ...